ZA927330B - Sparfloxacin solution and its preparation. - Google Patents

Sparfloxacin solution and its preparation.

Info

Publication number
ZA927330B
ZA927330B ZA927330A ZA927330A ZA927330B ZA 927330 B ZA927330 B ZA 927330B ZA 927330 A ZA927330 A ZA 927330A ZA 927330 A ZA927330 A ZA 927330A ZA 927330 B ZA927330 B ZA 927330B
Authority
ZA
South Africa
Prior art keywords
sparfloxacin
monocarboxylic
pharmaceutically acceptable
preparation
solution
Prior art date
Application number
ZA927330A
Other languages
English (en)
Inventor
Guillaume Conrath
Original Assignee
Rhone Dpc Europ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Dpc Europ filed Critical Rhone Dpc Europ
Publication of ZA927330B publication Critical patent/ZA927330B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
ZA927330A 1991-09-27 1992-09-24 Sparfloxacin solution and its preparation. ZA927330B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9111913A FR2681863B1 (fr) 1991-09-27 1991-09-27 Solution de sparfloxacine sa preparation et sel la constituant.

Publications (1)

Publication Number Publication Date
ZA927330B true ZA927330B (en) 1993-04-21

Family

ID=9417358

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927330A ZA927330B (en) 1991-09-27 1992-09-24 Sparfloxacin solution and its preparation.

Country Status (22)

Country Link
US (1) US5478829A (ja)
EP (2) EP0534860A1 (ja)
JP (1) JPH07503941A (ja)
AT (1) ATE168008T1 (ja)
AU (1) AU671602B2 (ja)
CA (1) CA2119270A1 (ja)
CZ (1) CZ69494A3 (ja)
DE (1) DE69226192D1 (ja)
FI (1) FI941399A0 (ja)
FR (1) FR2681863B1 (ja)
HU (1) HUT67672A (ja)
IL (1) IL103270A (ja)
MX (1) MX9205461A (ja)
NO (1) NO941036L (ja)
NZ (1) NZ244479A (ja)
PL (2) PL170495B1 (ja)
SG (1) SG59982A1 (ja)
SK (1) SK34894A3 (ja)
TW (1) TW202393B (ja)
WO (1) WO1993005782A1 (ja)
YU (1) YU86792A (ja)
ZA (1) ZA927330B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5103898A (en) * 1996-11-05 1998-05-29 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
EP1685843A1 (en) * 1999-06-30 2006-08-02 Ruey J. Dr. Yu Oligosaccharide aldonic acids and their topical use
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US6335023B1 (en) 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE19962353A1 (de) 1999-12-23 2001-07-05 Henkel Ecolab Gmbh & Co Ohg Hepatitis A Viruzid
US6979471B1 (en) * 2000-09-05 2005-12-27 Council Of Scientific And Industrial Research Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra
WO2003015752A1 (en) * 2001-08-14 2003-02-27 Bakulesh Mafatlal Khamar The process for preparing isotonic topical antibiotic ophthalmic formulation with improved therapeutic effect
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
TW200900066A (en) * 2007-03-22 2009-01-01 Daiichi Sankyo Co Ltd Quinolone medical composition containing alcohols
EP2712611A1 (en) * 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilized aqueous compositions of neuromuscular blocking agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤

Also Published As

Publication number Publication date
NO941036D0 (no) 1994-03-22
EP0605646B1 (fr) 1998-07-08
HU9400868D0 (en) 1994-06-28
US5478829A (en) 1995-12-26
FI941399A (fi) 1994-03-25
FI941399A0 (fi) 1994-03-25
AU2772292A (en) 1993-04-27
ATE168008T1 (de) 1998-07-15
CZ69494A3 (en) 1994-07-13
PL170495B1 (en) 1996-12-31
FR2681863B1 (fr) 1995-02-03
DE69226192D1 (de) 1998-08-13
NO941036L (no) 1994-03-22
IL103270A0 (en) 1993-02-21
PL170357B1 (en) 1996-12-31
EP0605646A1 (fr) 1994-07-13
MX9205461A (es) 1993-03-01
HUT67672A (en) 1995-04-28
TW202393B (ja) 1993-03-21
FR2681863A1 (fr) 1993-04-02
IL103270A (en) 1996-11-14
WO1993005782A1 (fr) 1993-04-01
CA2119270A1 (fr) 1993-04-01
SG59982A1 (en) 1999-02-22
NZ244479A (en) 1995-04-27
EP0534860A1 (fr) 1993-03-31
JPH07503941A (ja) 1995-04-27
AU671602B2 (en) 1996-09-05
YU86792A (sh) 1995-10-03
SK34894A3 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
AU563777B2 (en) Piperazine-quinoline derivatives in basic aqueous pharmaceutical preparations
ZA927330B (en) Sparfloxacin solution and its preparation.
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
AU581442B2 (en) 2-substituted-1, 3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
IL100621A0 (en) Tetrazole derivatives,their preparation and pharmaceutical compositions containing them
EP0353821A3 (en) Antipsychotic 3-piperazinyl-benzazole derivatives
TNSN89016A1 (fr) Procede pour la preparation d'esters d'acide cepheme - carboxylique
IL83086A0 (en) Stable,injectable solutions of vinca dimer salts
AU2426592A (en) New ganglioside derivatives
GR79382B (ja)
FR2616149B1 (fr) Nouveau derive de l'acide benzo (b) thiophene - 7 carboxylique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
IE901180L (en) Polar cephalosporin derivatives and a process for the¹preparation thereof
RU94019970A (ru) Водный раствор спарфлоксацина, способ его получения и соль спарфлоксацина и фармацевтическая композиция
ES8306729A1 (es) "procedimiento de obtencion de 2-isopropil pirido (2-1-b) quinazolinas y sus sales no toxicas con actividad antianafilactica".